Alternatives in blood operations when choosing non-DEHP bags

P. F. van der Meer, D. V. Devine, David O. Irving, Jason P. Acker, Axel Seltsam, Minoko Takanashi, Dirk de Korte, Femke Noorman, Ray Scott, Miguel Lozano, Rebecca Cardigan, Stephen J. Wagner, Claudia Cohn, Richard M. Kaufman, Beth Shaz, Ralph R. Vassallo, the Biomedical Excellence for Safer Transfusion (BEST) Collaborative

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


The use of di-ethylhexyl-phthalate (DEHP) in blood bags is under discussion due to toxicity concerns and possible restrictions. A questionnaire among 15 blood centres in nine countries showed that none so far have fully switched to non-DEHP blood bags. If centres had to change, sites with a 42-day outdate would choose for a shorter outdating period, while others would allow a higher haemolysis rate (but within current specifications). To improve red cell quality, about half of the centres are willing to move to an alternative red cell storage solution, while the other half would not change for various reasons.

Original languageEnglish (US)
Pages (from-to)183-184
Number of pages2
JournalVox Sanguinis
Issue number2
StatePublished - Feb 1 2017

Bibliographical note

Publisher Copyright:
© 2017 International Society of Blood Transfusion


  • DEHP
  • red cell additive solution
  • red cell quality
  • toxicity


Dive into the research topics of 'Alternatives in blood operations when choosing non-DEHP bags'. Together they form a unique fingerprint.

Cite this